Prostaprime
Prostaprime, licence 80096068: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Wellbeing Health Food
- NPN or DIN-HM
- 80096068
- Status
- Active licence
- Licence date
- 12 December 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Prunus africana (Hook. f.) Kalkman: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50.0:1.0 Dry plant equivalent : 2500.0 mg Potency : 6.0 % Terpene lactones | 50.0 mg | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 24.0 % Flavonoid glycosides | Not specified | Not calculated |
| Vitamine D Source : Cholécalciférol | 2.5 mcg | 5 µg |
| Serenoa repens Source : Fruit Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 1800.0 mg | 180.0 mg | Not calculated |
| Lycopène Source : Lycopène | 375.0 mcg | Not calculated |
| Zinc Source : Citrate de zinc | 7.5 mg | 15,000 µg |
| Urtica dioica Source : Racine Extract : Matériel brut sec Extraction ratio : 5.0:1.0 Dry plant equivalent : 250.0 mg | 50.0 mg | Not calculated |
| Lepidium meyenii Source : Racine Extract : Matériel brut sec Extraction ratio : 6.0:1.0 Dry plant equivalent : 900.0 mg | 150.0 mg | Not calculated |
| Panax ginseng Source : Racine Extract : Matériel brut sec Extraction ratio : 8.0:1.0 Dry plant equivalent : 240.0 mg Potency : 5.0 % Total ginsenosides | 30.0 mg | Not calculated |
| Prunus africana Source : Ecorce (tronc) Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 40.0 mg | 10.0 mg | Not calculated |
| Phytostérols Source : Glycine max - Graine | 25.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow/ incomplete voiding/frequent daytime /night time urination) associated with mild to moderate benign prostatic hyperplasia (BPH).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Stop use if you experience insomnia, anxiety or headaches.
- Contre-indications
Do not use if you are pregnant or breastfeeding. Do not use this product if you are taking health products that affect blood coagulation as this may increase the risk of spontaneous bleeding.
- Précautions et mises en garde
Consult a healthcare practitioner/health care provider/health care professional/doctor/ physician if symptoms persist or worsen. Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use to exclude a diagnosis of prostate cancer. Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you have high blood pressure. Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you are taking antidepressants, blood thinners or digoxin. Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you have diabetes. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking medications for diabetes, high blood pressure or seizures.
Source
Official Health Canada record, licence 80096068
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.